A traditional Chinese medicine composition for treating cerebrovascular diseases and a preparation method thereof
This traditional Chinese medicine preparation, composed of herbs such as Astragalus membranaceus and Rhodiola rosea, is used to treat ischemic stroke by invigorating qi, promoting blood circulation, removing blood stasis, and clearing the meridians. It solves the problems of narrow treatment window and high bleeding risk of Western medicine, realizes the recovery of neurological function and individualized treatment, and provides a safe and effective treatment plan.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- PEOPLES HOSPITAL AFFILIATED TO FUJIAN UNIV OF TRADITIONAL CHINESE MEDICINE (FUJIAN PROVINCIAL PEOPLES HOSPITAL)
- Filing Date
- 2026-04-17
- Publication Date
- 2026-07-17
AI Technical Summary
Existing Western medicines for treating ischemic stroke have problems such as a narrow time window, high risk of bleeding, single neuroprotective mechanism, and insufficient individualized treatment, making it difficult to effectively improve the long-term prognosis of cerebrovascular diseases.
The traditional Chinese medicine composition consists of Astragalus membranaceus, Rhodiola rosea, Angelica sinensis, Paeonia lactiflora, Ligusticum chuanxiong, Prunus persica, Carthamus tinctorius, and Pheretima aspergillum. It is prepared into various dosage forms of traditional Chinese medicine preparations by invigorating qi and promoting blood circulation, removing blood stasis and unblocking the meridians, and exerting multi-target effects on the pathophysiological process of ischemic stroke.
It extends the treatment time window, reduces the risk of bleeding, promotes the recovery of nerve function, improves the repair capacity of nerve cells, adapts to the needs of individualized treatment, and has the characteristics of high safety and few side effects.
Smart Images
Figure CN122398899A_ABST